Cargando…
The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancer
BACKGROUND: Postoperative adjuvant chemotherapy (AC) is now well-accepted as standard for high-risk stage II and stage III colorectal cancer (CRC) patients, however the optimal time to initiate AC remains elusive. METHODS: A comprehensive literature search was performed using the PubMed and Embase d...
Autores principales: | Yang, Yuchong, Lu, Yao, Tan, Hui, Bai, Ming, Wang, Xia, Ge, Shaohua, Ning, Tao, Zhang, Le, Duan, Jingjing, Sun, Yansha, Liu, Rui, Li, Hongli, Ba, Yi, Deng, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170689/ https://www.ncbi.nlm.nih.gov/pubmed/37161562 http://dx.doi.org/10.1186/s12885-023-10863-w |
Ejemplares similares
-
Third-line treatment patterns and clinical outcomes for metastatic colorectal cancer: a retrospective real-world study
por: Deng, Ting, et al.
Publicado: (2023) -
Sintilimab Plus Apatinib and Chemotherapy as Second‑/Third-Line treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a prospective, Single-Arm, phase II trial
por: Zhang, Le, et al.
Publicado: (2023) -
Optimal Time of Initiating Adjuvant Chemotherapy After Curative Surgery in Colorectal Cancer Patients
por: Kang, Kyu Min, et al.
Publicado: (2013) -
Efficacy and survival of anti-PD-1 antibody in combination with trastuzumab and chemotherapy versus trastuzumab and chemotherapy as first-line treatment of HER2-positive metastasis gastric adenocarcinoma: a retrospective study
por: Deng, Ting, et al.
Publicado: (2023) -
Impact of Adjuvant Chemotherapy in Patients With Curatively Resected Stage IV Colorectal Cancer
por: Kobayashi, Hirotoshi, et al.
Publicado: (2015)